Skip to main content Skip to search Skip to main navigation

Alternative Approach to Risk Assessment of Computerised Systems

Excerpt form the GMP Compliance Adviser, Chapter 9.D.2.2

9 min. reading time | by Dennis Sandkühler
Published in LOGFILE 26/2021

On the basis of the process-related requirements set out in the specifications, ISPE GAMP® 5 provides for a process risk analysis to identify risks relating to patient safety, product quality, data integrity and compliance requirements.

The aim is to obtain an indication of the risk that a requirement entails and whether further risk-minimising measures are required.The application of the Golden Circle method produces the following tasks required to achieve the goal of risk assessment of computerised systems:

  1. Create a user requirements specification (URS) with all regulatory and process requirements
  2. Identify unwanted effects and add the necessary risk-minimising measures as requirements in the URS
  3. Assign software and hardware category as per ISPE GAMP® 5 definition to the requirements set out in the URS
  4. Determine the GxP relevance for each requirement
  5. Determine the risk priority number
  6. Evaluate the risk priority number

Steps 1–3 are already described in 9.D.1 System classification as per ISPE GAMP® 5 and 9.E Validation of computerised systems and are therefore only briefly summarised here. Determination of GxP relevance, calculation of the risk priority number and its possible evaluation (steps 4–6) are explained below.

As a rule, computerised systems are made up of modules, components and functions that can be assigned to different software categories as per ISPE GAMP® 5 for fulfilment of a requirement . For example, an individually programmed interface is assigned to software category 5, while a standard monitoring system without configuration correlates to software category 3. For the risk assessment, each requirement can therefore be considered and evaluated separately.

Risk analysis methods can be used to identify potentially unwanted effects or missing requirements. The results should be added iteratively as a requirement in the URS and also subjected to a risk assessment.

Step 4: Determination of GxP relevance

ISPE GAMP® 5 provides a number of examples of risk assessment, but is not specific in terms of information concerning risk priority or the impact of unwanted effects on patient safety, product quality and data integrity of a computerised system. ISPE GAMP® 5 thus ultimately only follows the formulation of ICH Q9, to define qualitative descriptions such as “high”, “medium” or “low” in as much detail as possible. Quotations to this effect can be found in Figure 9.D-4.

Figure 9.D-4 Statements of ICH Q9 and ISPE GAMP® 5 on the classification of risks

As part of computer system validation, it is important to determine whether a function of the system can have an impact on patient safety, product quality and data integrity and is therefore GxP relevant. Another important aspect is whether a malfunction can have an indirect or direct influence. Where the risk of malfunction cannot be eliminated by technical measures, monitoring should be implemented and correction should be possible.

With the introduction of GxP relevance as an example of a risk-describing variable, the aspects that have been set out can be differentiated into five levels (Figure 9.D-5). These levels should be specified in greater detail by each user for their own particular risk management process.

Figure 9.D-5 Definition of GxP relevance

Step 5: Calculation of the risk priority number

The risk priority number for a requirement from the specifications for a computerised system is calculated from the ISPE GAMP® 5 category of the system and the GxP relevance as follows:

Risk priority number (RPN) = (ISPE GAMP® 5 category) x (GxP relevance)

Figure 9.D-6 Risk priority numbers from ISPE GAMP® 5 category and GxP relevance

Step 6: Evaluation of the risk priority number

The need for technical or organisational measures for the minimisation of risk is determined on the basis of the risk priority number for the requirement in question.

An example of a scheme for determination of the need for measures is shown in Figure 9.D-7.

Figure 9.D-7 Acceptance criteria and need for measures

This means that for requirements that have a risk priority number < 5, no technical or organisational measures are required and a simple functional test is sufficient. By contrast, measures are necessary for requirements with a risk priority number ≥ 15. For requirements with risk priority numbers between > 5 and < 15, measures are recommended.


Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Dr. Dennis Sandkühler
Dr. Dennis Sandkühler

You may also be interested in the following articles:

Question of the Week | GMP-Verlag

What are the Benefits and Limitations of Passive Temperature-Controlled Containers for Drug Transport?

Here's the answer:
Read more
Outsourced Activities in the GDP Environment Part II: Contractual Agreements

Outsourced Activities in the GDP Environment Part II: Contractual Agreements

When outsourcing GDP activities, there is a need for concrete delimitation of responsibilities between a client and a contractor. Read more about the goals and the contents of a quality agreement in the following excerpt from GMP:KnowHow Pharmalogistics (GDP).

Read more
FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

The FDA has updated its recommendations on Acceptable Intake (AI) limits for nitrosamine impurities. Under certain conditions, the Agency now accepts a Less-Than-Lifetime (LTL) adjustment of AI limits for medicinal products that are not intended for lifetime use. This also represents an alignment with the LTL concept of ICH M7(R2).
Read more
Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

As of 15 November 2026, active substances must be registered in the EMA's Substance Management Services (SMS) database before Swissmedic can include them in establishment licences and GMP certificates for active substance manufacturers. The new requirement results from modifications to the EudraGMDP database.
Read more
News: EMA

EMA: New Q&As for Biological Medicinal Products

The EMA has added a new section to its Q&As on biological medicinal products addressing medicinal products containing secretomes or extracellular vesicles (EVs) obtained from human or animal cells.
Read more
News: Europe

EU: Council Adopts the Pharmaceutical Package

On 28 September 2026, the Council of the European Union adopted the EU pharmaceutical package, marking another important step in the legislative process for the comprehensive reform of EU pharmaceutical legislation.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

With an named user licence, one user can access the knowledge portal; with a corporate licence, any number of users can access it.Approx. 5,000 pages of practical GMP knowledge with illustrations and forms: Practical guidance for rapid implementation in the workplaceDetailed descriptions of GMP-compliant systemsInternational laws and guidelines Always up-to-date thanks to regular updates Download Advantages and Prices60+ Sample Documents In addition, the GMP Compliance Adviser contains more than 60 sample documents (MS Office) and practical examples that you can use.Sample SOPsSample FormsSample ReportsSample DocumentationChecklistsProcess Diagrams (Flowcharts)Practical Examples of QRM Application (e.g., Risk Analyses)Sample Documents for Qualification and ValidationCase StudiesWritten by more than 80 authors with hands-on experience directly linked to the industryA team of over 80 experts interpret regulatory requirements and describe how they are implemented in practice.The authors are experienced in the pharmaceutical industry, consulting, and government agencies.

delivery immediately after receipt of payment
€1,368.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

Your knowledge portal for GDP-compliant pharmaceutical logistics.  It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

delivery immediately after receipt of payment
€610.00 net excl. VAT
E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes,content compliant with Article 7(4) of Directive 2003/94/EC.The Author This e-learning course was developed with the collaboration of Dipl.-Ing. Andreas Nuhn (D & B Pharmadesign GmbH).

delivery time appr. 2-5 workdays after receipt of payment
€245.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

delivery immediately after receipt of payment
€44.90 net excl. VAT